Enhanced IFNα Signaling Promotes Ligand-Independent Activation of ERα to Promote Aromatase Inhibitor Resistance in Breast Cancer
Taylor E. Escher(Northwestern University), Joan Lewis-Wambi(The University of Kansas Cancer Center)
Cited by 12
Related Papers
Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner
|Breast Cancer Research|2016|80
Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
|Breast Cancer Research|2008|65
Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death
|Breast Cancer Research|2015|62
RETRACTED ARTICLE: Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer
|Breast Cancer Research|2012|32
Expression of a RAS degrader via synthetic nanocarrier-mediated mRNA delivery reduces pancreatic tumors
|bioRxiv (Cold Spring Harbor Laboratory)|2024|0